GLP-1 ad war spills into court as Novo Nordisk alleges Eli Lilly ignores science - The Washington Post
- GLP-1 ad war spills into court as Novo Nordisk alleges Eli Lilly ignores science The Washington Post
- Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising CNBC
- Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads | Pharmaceuticals industry The Guardian
- Novo Nordisk says it’s suing Eli Lilly, accusing it of false advertising NBC News
- Novo Sues Rival Lilly Over Alleged False Advertising in Weight-Loss Ads WSJ
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events